Beta-blocker use and COPD mortality: a systematic review and meta-analysis

BACKGROUND: Despite the benefits of beta-blockers in patients with established or sub-clinical coronary artery disease, their use in patients with chronic obstructive pulmonary disease (COPD) has been controversial. Currently, no systematic review has examined the impact of beta-blockers on mortalit...

Descripción completa

Detalles Bibliográficos
Autores principales: Etminan, Mahyar, Jafari, Siavash, Carleton, Bruce, FitzGerald, John Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499441/
https://www.ncbi.nlm.nih.gov/pubmed/22947076
http://dx.doi.org/10.1186/1471-2466-12-48

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499441/
https://www.ncbi.nlm.nih.gov/pubmed/22947076
http://dx.doi.org/10.1186/1471-2466-12-48

Ejemplares similares